M. Noppe

发表

Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer.

Joel Rosenblatt, Geert Verreck, G. Verreck, 2003, Journal of controlled release : official journal of the Controlled Release Society.

Stable ciliary activity in human nasal epithelial cells grown in a perfusion system.

M. Brewster, M. Noppe, P. Augustijns, 2005, International journal of pharmaceutics.

Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery.

Jef Adriaensen, Claire Mackie, M. Brewster, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins.

J. Peeters, M. Brewster, M. Noppe, 2007, International journal of pharmaceutics.

The use of human nasal in vitro cell systems during drug discovery and development.

M. Brewster, M. Noppe, P. Augustijns, 2005, Toxicology in vitro : an international journal published in association with BIBRA.

Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum

Börje Karlsson, E. Hansson, L. Rönnbäck, 1984, Brain Research.

Primary cultures from defined brain areas; effects of seeding time on cell growth, astroglial content and protein synthesis.

E. Hansson, L. Rönnbäck, M. Noppe, 1985, Brain research.

Alpha-albumin (GFA) dosage and localization in human nervous tissue and cerebrospinal fluid.

M. Noppe, A. Lowenthal, J. Gheuens, 1979, Cellular and molecular biology, including cyto-enzymology.

A two-site immunoradiometric assay for the determination of α-albumin

M. Noppe, A. Lowenthal, J. Gheuens, 1979 .

Brain primary culture — A characterization (part II)

E. Hansson, L. Rönnbäck, C. Alling, 1982, Brain Research.

Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: effect on ciliary beat frequency.

M. Brewster, M. Noppe, P. Augustijns, 2003, International journal of pharmaceutics.

Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology.

M. Noppe, A. Lowenthal, R. Crols, 1986, Clinica chimica acta; international journal of clinical chemistry.

High‐speed digital imaging method for ciliary beat frequency measurement

Frederik Maes, F. Maes, M. Brewster, 2005, The Journal of pharmacy and pharmacology.

Humoral immune response in guinea pigs at different stages of experimental allergic encephalomyelitis.

H. Lassmann, M. Noppe, A. Lowenthal, 1984, Progress in clinical and biological research.

Cerebrospinal fluid proteins in neurology.

M. Noppe, A. Lowenthal, J. Gheuens, 1984, International review of neurobiology.

a-albumin (glial fibrillary acidic protein) in normal and pathological human brain and cerebrospinal fluid

M. Noppe, A. Lowenthal, J. Gheuens, 1978, Journal of Neurology.

Identification of Several Forms of the Glial Fibrillary Acidic Protein, or α‐Albumin, by a Specific Monoclonal Antibody

E. Schutter, M. Noppe, A. Lowenthal, 1984, Journal of neurochemistry.

Auto-antibodies to brain specific proteins

M. Noppe, A. Lowenthal, J. Gheuens, 1984 .

α-Albumin in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases — comparison with other brain specific proteins

M. Noppe, A. Lowenthal, R. Crols, 1984 .

α-Albumin (GFA) as a marker of astrocytic involvement in human cerebrospinal fluid

M. Noppe, A. Lowenthal, J. Caers, 1983 .

Glial Cells Identified by Anti‐α‐Albumin (Anti‐GFA) in Human Pineal Gland

M. Noppe, J. Brion, A. Lowenthal, 1982, Journal of neurochemistry.

Immunochemical determination and immunocytological localization of brain-specific protein α-albumin (GFA) in isolated astrocytes

M. Noppe, A. Lowenthal, J. Gheuens, 1980, Neurochemical Research.

Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors.

M. Janicot, M. Noppe, L. van Hijfte, 2010, Bioorganic & medicinal chemistry letters.

Serological identification of viral antigens after electrophoretic transfer.

M. Noppe, H. Thormar, A. Lowenthal, 1981, Journal of immunological methods.

Value of glial fibrillary acidic protein determination in amniotic fluid for prenatal diagnosis of neural tube defects.

E. Vámos, M. Noppe, A. Lowenthal, 1987, Clinica chimica acta; international journal of clinical chemistry.

Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.

Bart Willems, M. Brewster, J. Mensch, 2004, Journal of pharmaceutical sciences.

A two-site immunoradiometric assay for the determination of alpha-albumin.

M. Noppe, A. Lowenthal, J. Gheuens, 1979, Journal of immunological methods.

A serum protein affecting the regulation of the immune system

M. Noppe, A. Lowenthal, D. Karcher, 1984, Neurochemical Research.

Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach.

M. Brewster, M. Janicot, M. Noppe, 2008, Die Pharmazie.

The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals.

G. Verreck, I. Chun, J. Peeters, 2004, Die Pharmazie.

Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone.

X. Langlois, M. Brewster, V. Préat, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome

M. Noppe, J. Saerens, A. Lowenthal, 1986, Journal of Neurology.

Passive diffusion of polymeric surfactants across lipid bilayers.

M. Brewster, V. Préat, M. Noppe, 2007, Journal of controlled release : official journal of the Controlled Release Society.

The Use of Solubilizing Excipients and Approaches to GenerateToxicology Vehicles for Contemporary Drug Pipelines

M. Brewster, M. Noppe, C. Mackie, 2007 .

Usefulness of a novel Caco-2 cell perfusion system II. Characterization of monolayer properties and peptidase activity.

M. Brewster, J. Mensch, M. Noppe, 2009, Die Pharmazie.

SIGNIFICATION OF GLIAL FIBRILLARY ACIDIC PROTEIN IN PATHOLOGY

M. Noppe, A. Lowenthal, J. Gheuens, 1980 .

alpha-Albumin (glial fibrillary acidic protein) in normal and pathological human brain and cerebrospinal fluid.

M. Noppe, A. Lowenthal, J. Gheuens, 1978, Journal of neurology.